Stock listing

Bolt Biotherapeutics, Inc.

Selected listing: A419U9 · LS · EUR · DE

Bolt Biotherapeutics, Inc. (Lang & Schwarz: A419U9), Health Technology. Latest release Aug 11, 2026: Bolt Biotherapeutics Reports Second Quarter 2026…

A419U9:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A419U9
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 11, 2026

Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

March 12, 2026

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 12, 2025

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

October 1, 2025

All Bolt Biotherapeutics, Inc. news →

Events

Replays

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call
Tue, May 14, 2024 · 04:30 PM ET
Watch

Research Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. company profile

View the public company page for Bolt Biotherapeutics, Inc. on 6ix.

Bolt Biotherapeutics, Inc. news

Read company news and market updates connected to Bolt Biotherapeutics, Inc..

Bolt Biotherapeutics, Inc. investor events

Find investor webinars, events, and replay context for Bolt Biotherapeutics, Inc..